Emma R. Parmee

Statistics

Publications

Citations

2.2K

H-Index

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Emma R. Parmee is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1989–2022

Publications

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Linda Brockunier, Emma R. Parmee, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 199 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

New catalysts for the asymmetric aldol reaction: chiral boranes prepared from .alpha.,.alpha.-disubstituted glycine arenesulfonamides

Emma R. Parmee, Orin Tempkin, Satoru Masamune et al. · Journal of the American Chemical Society · 1991 · 179 citations

Natural Sciences, Chemistry, Catalysis +12

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 137 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and Inhibitor Specificity

Giovanna Scapin, Sangita B. Patel, Jeffrey P. Varnerin et al. · Biochemistry · 2004 · 119 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

M. H. FISHER, A Amend, Tom Bach et al. · Journal of Clinical Investigation · 1998 · 115 citations · Full text

Life Sciences, Pharmacology, Physiology +17

1–5 of 41